Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Current Assets: 2022-2024

Historic Current Assets for Entrada Therapeutics (TRDA) over the last 3 years, with Dec 2024 value amounting to $440.0 million.

  • Entrada Therapeutics' Current Assets fell 27.31% to $338.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $338.3 million, marking a year-over-year decrease of 27.31%. This contributed to the annual value of $440.0 million for FY2024, which is 19.00% up from last year.
  • According to the latest figures from FY2024, Entrada Therapeutics' Current Assets is $440.0 million, which was up 19.00% from $369.8 million recorded in FY2023.
  • Entrada Therapeutics' Current Assets' 5-year high stood at $440.0 million during FY2024, with a 5-year trough of $209.9 million in FY2022.
  • In the last 3 years, Entrada Therapeutics' Current Assets had a median value of $369.8 million in 2023 and averaged $339.9 million.
  • Data for Entrada Therapeutics' Current Assets shows a peak YoY spiked of 76.19% (in 2023) over the last 5 years.
  • Over the past 3 years, Entrada Therapeutics' Current Assets (Yearly) stood at $209.9 million in 2022, then soared by 76.19% to $369.8 million in 2023, then climbed by 19.00% to $440.0 million in 2024.